Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +9
  • Study on How Mepolizumab Affects Patients with Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on Reducing Biologic Treatments Mepolizumab and Dupilumab for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark
  • Study of Tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

    Recruiting

    3 1 1
    Belgium Bulgaria Denmark Finland Germany Hungary +5
  • Study on Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps and Eosinophilic Otitis Media

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on Mepolizumab and Surgery for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark
  • Study on Mepolizumab and Nasal Polypectomy for Patients with Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • Comparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Hungary +5